Balyasny Asset Management LLC Bristol Myers Squibb CO Transaction History

Balyasny Asset Management LLC

  • $54.8 Billion
  • Q1 2024

A detailed history of Balyasny Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Balyasny Asset Management LLC holds 26,400 shares of BMY stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,400
Previous 76,918 65.68%
Holding current value
$1.1 Million
Previous $3.95 Million 63.74%
% of portfolio
0.0%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$47.98 - $54.4 $1.08 Million - $1.23 Million
-22,594 Reduced 29.37%
54,324 $2.95 Million
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $46.6 Million - $55.6 Million
-960,724 Reduced 92.59%
76,918 $3.95 Million
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $8.51 Million - $9.52 Million
147,039 Added 16.51%
1,037,642 $60.2 Million
Q2 2023

Aug 14, 2023
BUY
$63.71 - $70.74 $18.4 Million - $20.4 Million
288,296 Added 47.87%
890,603 $57 Million
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $39.6 Million - $44.9 Million
602,307 New
602,307 $41.7 Million
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $31,115 - $18.4 Million
239,352 Added 49.95%
718,488 $51.1 Million
Q2 2022

Aug 15, 2022
BUY
$72.62 - $79.98 $2.12 Million - $2.33 Million
29,171 Added 6.48%
479,136 $36.9 Million
Q1 2022

May 16, 2022
SELL
$61.48 - $73.72 $4.95 Million - $5.93 Million
-80,473 Reduced 15.17%
449,965 $32.9 Million
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $24.6 Million - $28.8 Million
415,856 Added 362.93%
530,438 $31.4 Million
Q2 2021

Aug 16, 2021
SELL
$61.91 - $67.42 $33 Million - $35.9 Million
-532,898 Reduced 82.3%
114,582 $7.66 Million
Q1 2021

May 17, 2021
BUY
$59.34 - $66.74 $14.1 Million - $15.9 Million
238,438 Added 58.29%
647,480 $40.9 Million
Q4 2020

Feb 16, 2021
BUY
$57.74 - $65.43 $22.9 Million - $26 Million
396,948 Added 3282.19%
409,042 $25.4 Million
Q2 2020

Aug 14, 2020
SELL
$54.82 - $64.09 $17.3 Million - $20.2 Million
-315,551 Reduced 96.31%
12,094 $711,000
Q1 2020

May 15, 2020
BUY
$46.4 - $67.43 $10.8 Million - $15.6 Million
232,090 Added 242.89%
327,645 $18.3 Million
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $1.42 Million - $1.85 Million
28,794 Added 43.13%
95,555 $6.13 Million
Q2 2019

Aug 14, 2019
SELL
$44.62 - $49.34 $12 Million - $13.3 Million
-269,704 Reduced 80.16%
66,761 $3.03 Million
Q1 2019

May 15, 2019
BUY
$45.12 - $53.8 $2.94 Million - $3.51 Million
65,168 Added 24.02%
336,465 $16.1 Million
Q4 2018

Feb 14, 2019
SELL
$48.76 - $63.23 $39.2 Million - $50.9 Million
-804,944 Reduced 74.79%
271,297 $14.1 Million
Q3 2018

Nov 14, 2018
BUY
$55.19 - $62.25 $28.8 Million - $32.5 Million
521,635 Added 94.06%
1,076,241 $66.8 Million
Q2 2018

Aug 14, 2018
BUY
$50.53 - $62.98 $6.18 Million - $7.7 Million
122,271 Added 28.28%
554,606 $30.7 Million
Q1 2018

May 15, 2018
SELL
$59.92 - $68.98 $40.7 Million - $46.9 Million
-679,353 Reduced 61.11%
432,335 $27.3 Million
Q4 2017

Feb 14, 2018
SELL
$59.94 - $65.35 $26.4 Million - $28.8 Million
-441,171 Reduced 28.41%
1,111,688 $68.1 Million
Q3 2017

Nov 14, 2017
BUY
$55.23 - $63.74 $85.8 Million - $99 Million
1,552,859
1,552,859 $99 Million

Others Institutions Holding BMY

# of Institutions
2,554
Shares Held
1.49B
Call Options Held
25.9M
Put Options Held
20M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $88.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email